The Wall Street Journal-20080118-Today-s Agenda
Return to: The_Wall_Street_Journal-20080118
Today's Agenda
Merck, Plaintiffs Discuss
Progress in Deal on Vioxx
Attorneys for Merck and Vioxx plaintiffs will give a status report in court and may discuss a controversial aspect of the $4.85 billion settlement that requires attorneys to recommend the deal to all or none of their Vioxx clients. Merck is confident enough plaintiffs will sign on to seal the deal.
GE Expected to Post a Rise;
Leading Indicators to Fall
General Electric's results will illuminate how much companies can rely on overseas growth to offset U.S. weakness. CEO Jeffrey Immelt said in October the year's final quarter would be a "boomer."
---
The index of leading indicators for December is forecast to drop, but by less than in November.
The Conference Board, 10 a.m. EST.
